News – Page 1074 – Endpoints News

SIGN UP

Boehringer strikes €307M collaboration deal with MiNA; Tricida banks $57.5M venture round for PhIII

8 years ago

Kerrisdale’s Sahm Adrangi leads a brutal new biotech short attack as trial results loom

8 years ago

German biotech InflaRx raises $100M in IPO

8 years ago

Struggling GSK recruits cancer drug guru Hal Barron as its new R&D chief

8 years ago

Amgen bets on stem cell company Fortuna Fix in $25M round

8 years ago

OncoSec shares turn hot as microcap reports promising PhII data for an I/O one-two punch

8 years ago

Who are the top 10 players that dominate the cancer drug market? And who's growing fastest?

8 years ago

An early SITC loser: Five Prime shares crushed as analysts fret over a snapshot on lead drug data

8 years ago

How much is your vision worth? Spark CEO Jeff Marrazzo has a price in mind

8 years ago

Mumbai-based Lupin gets FDA warning for two manufacturing sites; Ionis promotes inotersen head as new COO

8 years ago

Upstart Oyster Point has big plans for disrupting the ophthalmology space, but you'll have to wait for the details

8 years ago

Boasting in-license distribution model, Chinese EOC Pharma bags $32M series B funding for oncology products

8 years ago

FDA gives Cellectis a green light to relaunch off-the-shelf CAR-T studies — with several strings attached

8 years ago

Watch out Sanofi: Takeda's new data on dengue vaccine is good news for PhIII trial

8 years ago

Japanese CMO Fujifilm Diosynth spends extra $28M in US, UK mAb facilities

8 years ago

The Department of Defense could undermine FDA, giving the green light for experimental products

8 years ago

Senator Harris comes out swinging against Alkermes and its CEO, attacking an opioid drug franchise

8 years ago

Say it with us: IQVIA is the new Quintiles and IMS Health

8 years ago

Visualize: Just how much did biotech unicorn Moderna rely on immigrants to build the staff?

8 years ago

Amgen is shaking up R&D (again), chopping 200 as Genentech targets 130 layoffs

8 years ago

Novartis pitches two new CAR-T applications to EMA; J&J reports positive data for lupus program

8 years ago

Valeant hands off its controversial, $1B female libido drug to Sprout backers in sweetheart deal

8 years ago

Bill Gates and rich allies help fund an alt-biotech startup path for the gene expression experts at Exicure

8 years ago

For 3rd time, the FDA and its new commissioner dropped safety issues and trial demands, clearing the path for snubbed ...

8 years ago

First page Previous page 1071 1072 107310741075 1076 1077 Next page Last page